Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06036784 |
|
Recruitment Status :
Recruiting
First Posted : September 14, 2023
Last Update Posted : February 22, 2024
|
Sponsor:
MBX Biosciences
Collaborator:
ProSciento, Inc.
Information provided by (Responsible Party):
MBX Biosciences
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | October 17, 2024 |
| Estimated Study Completion Date : | October 17, 2024 |